Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
March 10th, 2026
CalPrivacy’s School Platform Action Highlights Opt-Outs, Protections for Vulnerable Users
Privacy Daily quotes Andrew Folks in the article, “CalPrivacy’s School Platform Action Highlights Opt-Outs, Protections for Vulnerable.” Last week’s $1.1 million California Consumer Privacy Act (CCPA) settlement with PlayOn Sports—a high school sports website—requires the company to conduct risk assessments, provide clearer disclosures, and improve its opt‑out methods.
The settlement underscores how CCPA is prioritizing effective opt‑out protections for vulnerable populations, business attorneys, and consumers. According to Folks, the case is especially significant because the site “was fined $1.1 million despite fixing its website and notices before CalPrivacy even made contact.” He further emphasized that, as with “nearly all of these CCPA cases, it’s important for businesses to audit their opt‑outs… reliance on third‑party industry tools, just like reliance on vendor tools, should be a business priority.”
Read the full Privacy Daily article for more details on the CCPA settlement. (Behind paywall)
Other Quoted
‘I have been hunted down by HR reps, lawyers, and comms people:’ Developers discuss the pain and prevalence of side work clauses
Wendy Stryker was quoted in a Game Developer article discussing "side work clauses," also known as "moonlighting clauses," in video game industry employment contracts. Read more.
July 30 2026
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
What Cannes Lions Can Teach Us About Advertising’s Most Important Customer
Cannes Lions brought important conversations to the stage about advertising’s most important stakeholder: the public. Read more.
July 2 2026
